Treatment of Ovarian Hyperstimulation Syndrome in a Mouse Model by Cannabidiol, an Angiogenesis Pathway Inhibitor

Studies suggest that ovarian hyperstimulation syndrome (OHSS) can be treated by reducing the level of vascular endothelial growth factor (VEGF). However, due to the side effects of commercially available VEGF-reducing drugs, they can be ruled out as a suitable treatment for OHSS; therefore, research...

Descripción completa

Detalles Bibliográficos
Autores principales: Tahermanesh, Kobra, Hakimpour, Sahar, Govahi, Azam, Keyhanfar, Fariborz, Kashi, Abolfazl Mehdizadeh, Chaichian, Shahla, Shahriyaripour, Roya, Ajdary, Marziyeh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797301/
https://www.ncbi.nlm.nih.gov/pubmed/36588534
http://dx.doi.org/10.1155/2022/1111777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9797301/
https://www.ncbi.nlm.nih.gov/pubmed/36588534
http://dx.doi.org/10.1155/2022/1111777

Ejemplares similares